Experimental trials of psychedelic drugs in both humans and animals have produced conflicting results, creating doubts about whether hallucinogens have a therapeutic role in treating neurologic or behavioral disorders such as depression and PTSD.
Inconsistent Findings in Mouse Studies Challenge Psilocybin's Therapeutic Potential
Researchers conducted parallel studies on psilocybin's effects in mice, finding inconsistent results that challenge its potential therapeutic benefits for conditions like depression and PTSD. This research is significant as it raises questions about the efficacy of psychedelic treatments, which could influence mental health policies in Iran. Understanding these findings is crucial for Iran's approach to mental health interventions.
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%